TIZIANA LIFE SCIENCES ORD 3P overview
TIZIANA LIFE SCIENCES ORD 3P > News
GlobeNewsWire published a news.
Tiziana Life Sciences Announces Data Demonstrating StemPrintER’s Superiority Compared to Oncotype DX in Providing Prognostic Information to Conventional Clinical Parameters in Breast Cancer Patients in Poster Discussion Session at the American Society of Clinical Oncology (ASCO) Virtual Conference
•
•
GlobeNewsWire •
Stocks •
More TIZIANA LIFE SCIENCES ORD 3P news...
Thank you